Trial Profile
Clinical Trials Insight: 700031172
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Mar 2008
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Fosbretabulin (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- Sponsors Mateon Therapeutics
- 05 Mar 2008 New trial record.
- 29 Feb 2008 Trial results are expected in the second half of 2008.